Argyle Capital Management LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 32.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 15,782 shares of the company's stock after acquiring an additional 3,838 shares during the quarter. Argyle Capital Management LLC's holdings in GE HealthCare Technologies were worth $1,234,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. boosted its holdings in shares of GE HealthCare Technologies by 10.1% during the 3rd quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company's stock worth $1,289,000 after purchasing an additional 1,256 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of GE HealthCare Technologies by 2.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 76,349 shares of the company's stock valued at $7,165,000 after acquiring an additional 1,920 shares during the last quarter. Valmark Advisers Inc. purchased a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $222,000. Golden State Equity Partners acquired a new stake in GE HealthCare Technologies during the third quarter worth about $532,000. Finally, Folger Nolan Fleming Douglas Capital Management Inc. acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at about $221,000. Hedge funds and other institutional investors own 82.06% of the company's stock.
GE HealthCare Technologies Stock Performance
GEHC stock traded down $2.21 on Tuesday, hitting $84.24. The company's stock had a trading volume of 2,678,454 shares, compared to its average volume of 2,892,884. The stock has a market cap of $38.52 billion, a price-to-earnings ratio of 19.41, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80. The firm has a 50 day moving average of $86.31 and a two-hundred day moving average of $86.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts recently commented on the company. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Citigroup upped their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and a consensus price target of $97.67.
Read Our Latest Report on GE HealthCare Technologies
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Further Reading
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
